Intravenous umbilical cord mesenchymal stem cell infusion for the treatment of combined malnutrition nonunion of the humerus and radial nerve injury

Regenerative Medicine

Volumn 6, Issue 6, 2011, Pages 733-741

  Xue, Guofang ^a   He, Meilan ^b   Zhao, Jie ^a   Chen, Yan ^a   Tian, Yun ^c   Zhao, Baozhen ^a   Niu, Bo ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c PEKING UNIVERSITY   (China)

Author keywords

mesenchymal stem cell; nonunion; peripheral nerve injury; umbilical cord

Indexed keywords

ADULT; ARTICLE; BONE RADIOGRAPHY; CASE REPORT; CLINICAL EXAMINATION; CORD BLOOD STEM CELL TRANSPLANTATION; ELECTROMYOGRAPHY; FEMALE; FLOW CYTOMETRY; FRACTURE NONUNION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCLE STRENGTH; MUSCLE TONE; NERVE CONDUCTION; NERVE INJURY; PRIORITY JOURNAL; RADIAL NERVE; STEM CELL EXPANSION; THERAPY EFFECT; TREATMENT OUTCOME;

ELECTROMYOGRAPHY; FEMALE; FRACTURES, UNUNITED; HUMANS; HUMERAL FRACTURES; INFUSIONS, INTRAVENOUS; MALNUTRITION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MIDDLE AGED; OSTEOGENESIS; PHENOTYPE; QUALITY CONTROL; RADIAL NERVE; UMBILICAL CORD;

EID: 82955197463     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.11.83     Document Type: Article

References (45)

1. Pollock FH, Drake D, Bovill EG et al. Treatment of radial neuropathy associated with fractures of the humerus. J. Bone Joint Surg. Am. 63(2), 239-243 (1981) (Pubitemid 11154536)
2. Thomsen NO, Dahlin LB. Injury to the radial nerve caused by fracture of the humeral shaft: Timing and neurobiological aspects related to treatment and diagnosis. Scand. J. Plast. Reconstr. Surg. Hand Surg. 41(4), 153-157 (2007)
3. Kurpisz M, Czepczynski R, Grygielska B et al. Bone marrow stem cell imaging after intracoronary administration. Int. J. Cardiol. 121(2), 194-195 (2007) (Pubitemid 47381321)
4. Tseng SS, Lee MA, Reddi AH. Nonunions and the potential of stem cells in fracture-healing. J. Bone Joint Surg. Am. 90(Suppl. 1), 92-98 (2008) (Pubitemid 351329127)
5. Vilquin JT, Rosset P. Mesenchymal stem cells in bone and cartilage repair: Current status. Regen. Med. 1(4), 589-604 (2006)
6. Marcacci M, Kon E, Moukhachev V et al. Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng. 13(5), 947-955 (2007) (Pubitemid 46870419)
7. Wu KH, Zhou B, Lu SH et al. In vitro and in vivo differentiation of human umbilical cord derived stem cells into endothelial cells. J. Cell Biochem. 100(3), 608-616 (2007). (Pubitemid 46180525)
8. Forraz N, McGuckin CP. The umbilical cord: A rich and ethical stem cell source to advance regenerative medicine. Cell Prolif. 44(Suppl. 1), 60-69 (2011).
9. Zeddou M, Briquet A, Relic B et al. The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood. Cell Biol. Int. 34(7), 693-701 (2010)
10. Xu HH, Zhao L, Detamore MS et al. Umbilical cord stem cell seeding on fast-resorbable calcium phosphate bone cement. Tissue Eng. Part A 16(9), 2743-2753 (2010)
11. Csaki C, Matis U, Mobasheri A et al. Co-culture of canine mesenchymal stem cells with primary bone-derived osteoblasts promotes osteogenic differentiation. Histochem. Cell Biol. 131(2), 251-266 (2009)
12. Wang L, Ott L, Seshareddy K et al. Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells. Regen. Med. 6(1), 95-109 (2011)
13. Zhang YN, Lie PC, Wei X. Differentiation of mesenchymal stromal cells derived from umbilical cord Wharton's jelly into hepatocyte-like cells. Cytotherapy 11(5), 548-558 (2009)
14. Anzalone R, Lo Iacono M, Corrao S et al. New emerging potentials for human Wharton's jelly mesenchymal stem cells: Immunological features and hepatocyte-like differentiative capacity. Stem Cells Dev. 19(4), 423-438 (2010)
15. Anzalone R, Lo Iacono M, Loria T et al. Wharton's jelly mesenchymal stem cells as candidates for b cells regeneration: Extending the differentiative and 1 Pollock FH, Drake D, Bovill EG et al. Treatment of radial neuropathy associated with fractures of the humerus. J. Bone Joint Surg. Am. 63(2), 239-243 (1981)
16. Alaminos M, Perez-Kohler B, Garzon I et al. Transdifferentiation potentiality of human Wharton's jelly stem cells towards vascular endothelial cells. J. Cell. Physiol. 223(3), 640-647 (2010)
17. Schneider RK, Pullen A, Kramann R et al. Long-term survival and characterisation of human umbilical cord-derived mesenchymal stem cells on dermal equivalents. Differentiation 79(3), 182-193 (2010)
18. Matsuse D, Kitada M, Kohama M et al. Human umbilical cord-derived mesenchymal stromal cells differentiate into functional Schwann cells that sustain peripheral nerve regeneration. J. Neuropathol. Exp. Neurol. 69(9), 973-985 (2010)
19. Zhang HT, Fan J, Cai YQ et al. Human Wharton's jelly cells can be induced to differentiate into growth factor-secreting oligodendrocyte progenitor-like cells. Differentiation 79(1), 15-20 (2010)
20. Prasanna SJ, Gopalakrishnan D, Shankar SR et al. Pro-inflammatory cytokines, IFNg and TNFa, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One 5(2), e9016 (2010)
21. La Rocca G, Anzalone R, Corrao S et al. Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: Differentiation potential and detection of new markers. Histochem. Cell. Biol. 131(2), 267-282 (2009)
22. Schallmoser K, Bartmann C, Rohde E et al. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47(8), 1436-1446 (2007) (Pubitemid 47101060)
23. Chase LG, Lakshmipathy U, Solchaga LA et al. A novel serum-free medium for the expansion of human mesenchymal stem cells. Stem. Cell. Res. Ther. 1(1), 8 (2010)
24. Ringden O, Uzunel M, Rasmusson I et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81(10), 1390-1397 (2006) (Pubitemid 43847148)
25. Kebriaei P, Isola L, Bahceci E et al. Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. Biol. Blood Marrow Transplant. 15(7), 804-811 (2009)
26. Deuse T, Stubbendorff M,Tang-Quan K et al. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplant. 20, 655-667 (2010)
27. Weiss ML, Anderson C, Medicetty S et al. Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 26(11), 2865-2874 (2008)
28. Troyer DL, Weiss ML. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 26(3), 591-599 (2008)
29. Lowe JB 3rd, Sen SK, MacKinnon SE. Current approach to radial nerve paralysis. Plast. Reconstr. Surg. 110(4), 1099-1113 (2002) (Pubitemid 34913350)
30. Weiss ML, Medicetty S, Bledsoe AR et al. Human umbilical cord matrix stem cells: Preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 24(3), 781-792 (2006) (Pubitemid 44464783)
31. Wang HS, Hung SC, Peng ST et al. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22(7), 1330-1337 (2004)
32. Lund RD, Wang S, Lu B et al. Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease. Stem Cells 25(3), 602-611 (2007) (Pubitemid 46354218)
33. Yang CC, Shih YH, Ko MH et al. Transplantation of human umbilical esenchymal stem cells from Wharton's jelly after complete transection of the rat spinal cord. PLoS ONE 3, e3336 (2008)
34. Chen K, Wang D, Du WT et al. Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism. Clin. Immunol. 135(3), 448-458 (2010)
35. Liao W, Zhong J, Yu J et al. Therapeutic benefit of human umbilical cord derived mesenchymal stromal cells in intracerebral hemorrhage rat: Implications of anti-inflammation and angiogenesis. Cell. Physiol. Biochem. 24(3-4), 307-316 (2009)
36. Kumar S, Wan C, Ramaswamy G et al. Mesenchymal stem cells expressing osteogenic and angiogenic factors synergistically enhance bone formation in a mouse model of segmental bone defect. Mol. Ther. 18(5), 1026-1034 (2010)
37. Kemp SW, Walsh SK, Midha R. Growth factor and stem cell enhanced conduits in peripheral nerve regeneration and repair. Neurol. Res. 30(10), 1030-1038 (2008)
38. Peng J, Wang Y, Zhang L et al.Human umbilical cord Wharton's jelly-derived mesenchymal stem cells differentiate into a Schwann-cell phenotype and promote neurite outgrowth in vitro. Brain Res. Bull. 84(3), 235-243 (2011)
39. Borel JF, Feurer C, Gubler HU et al. Biological effects of cyclosporin A: A new antilymphocytic agent. 1976. Agents Actions 43(3-4), 179-186 (1994)
40. Cho PS, Messina DJ, Hirsh EL et al. Immunogenicity of umbilical cord tissue derived cells. Blood 111(1), 430-438(2008)
41. Cutler AJ, Limbani V, Girdlestone J et al. Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T-cell proliferation. J. Immunol. 185(11), 6617-6623 (2010)
42. Tipnis S, Viswanathan C, Majumdar AS. Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: Role of B7-H1 and IDO. Immunol. Cell. Biol. 88(8), 795-806 (2010)
43. Wu KH, Chan CK, Tsai C et al. Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells. Transplantation 91(12), 1412-1416 (2011)
44. Medicetty S, Bledsoe AR, Fahrenholtz CB et al. Transplantation of pig stem cells into rat brain: Proliferation during the first 8 weeks. Exp. Neurol. 190(1), 32-41(2004) (Pubitemid 39335704)
45. Weiss ML, Mitchell KE, Hix JE et al. Transplantation of porcine umbilical cord matrix cells into the rat brain. Exp. Neurol. 182(2), 288-299 (2003). (Pubitemid 36937082)